A Study to Compare the Efficacy and Safety of SRSD107 and Enoxaparin in Adult Subjects Undergoing TKA

NCT07140523 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

450

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Thromboembolism

Interventions

DRUG: SRSD107
DRUG: enoxaparin

Sponsor

Sirius Therapeutics Co., Ltd.